🏠Home πŸ“–Fundamentals 🧠Stroke Analysis πŸŽ“Coach Library 🎬Video Library πŸ“šTechnical Reference πŸ’‘Knowledgebase ⚑Tennis Evolution πŸ“Blog πŸ“•Master Book πŸ“šBooks Catalog
Skip to content

Platelet-Rich Plasma (PRP) in Chronic Tendinopathy: LR-PRP vs. LP-PRP Efficacy Analysis

Author: Henry Phẑm Đức · Tennis Future Lab & Kinetic Biomechanics Research
Domain: Sports Medicine, Kinetic Chain Injury Prevention & Recovery
Source Vaults: Sports Medicine & Kinetic Chain Injury Prevention Β· Sports Medicine
Keywords: Platelet-Rich Plasma (PRP), Leukocyte-Rich PRP (LR-PRP), Leukocyte-Poor PRP (LP-PRP), Tendinopathy Healing, Tenocyte Regeneration


Executive Abstract

In chronic, non-responsive tennis tendinopathies, Platelet-Rich Plasma (PRP) delivers high concentrations of autologous growth factors (PDGF, TGF-Ξ², VEGF). Clinical evidence demonstrates that Leukocyte-Poor PRP (LP-PRP) is optimal for joint and cartilage healing to minimize catabolic inflammation, whereas Leukocyte-Rich PRP (LR-PRP) produces superior tenocyte regeneration in chronic recalcitrant Lateral Epicondylalgia (Tennis Elbow) when combined with eccentric loading.

β”Œβ”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”
β”‚              SPORTS MEDICINE: CLINICAL BIOMECHANICS & RTP MAP               β”‚
β”‚                                                                             β”‚
β”‚ [Phase 1: Pathophysiological Diagnosis & 6-Link Kinetic Chain Audit]        β”‚
β”‚                                  β”‚                                          β”‚
β”‚ [Phase 2: Mechanotransduction & Tissue Remodeling (Isometrics ──► Eccentrics)]β”‚
β”‚                                  β”‚                                          β”‚
β”‚ [Phase 3: Structural Correction & Mobility Restoration (T-Spine / Capsule)] β”‚
β”‚                                  β”‚                                          β”‚
β”‚ [Phase 4: High-Speed 240fps Biomechanical Error Elimination] ──► πŸ›‘οΈ        β”‚
β”‚                                  β”‚                                          β”‚
β”‚ [Phase 5: Criterion-Based Return-to-Play (> 90% Strength Symmetry)]         β”‚
β””β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”˜

1. Growth Factor Signaling & Angiogenesis Cascades

Platelet alpha granules release cytokines that stimulate quiescent tenocytes to produce fresh Type I collagen fibrils.

       [ Kinetic Energy Leak Detected ] ──► [ Eccentric Mechanotransduction ]
                                                        β”‚
       [ > 90% Strength Symmetry RTP ] β—„β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”˜
        (240fps Biomechanical Clearance + Tissue Remodeling)

2. LR-PRP vs. LP-PRP Biological Formulation

Matching the leukocyte concentration to the target tissue (LR-PRP for tendon vs. LP-PRP for intra-articular joints) determines clinical success.


3. Post-PRP Progressive Loading Protocol

2-Week immobilization/protection phase followed by progressive isometric and eccentric mechanical loading to align regenerating fibers.


Clinical Diagnostic & Technical Remediation Matrix

Pathological Parameter Common Technical Fault Clinical / Functional Risk Prescribed Clinical Intervention
Joint Loading Fault Resuming Heavy Play 3 Days Post-PRP: Playing high-intensity matches immediately after PRP injection Disrupting the newly forming platelet clot and causing tendon rupture 2-Week Biological Window: Respect the 14-day cellular healing phase before initiating progressive eccentric loading.
Mobility Restriction Stiff thoracic spine or tight posterior capsule Compensatory lumbar disc & rotator cuff breakdown Mobilize Daily: Foam roller thoracic extensions and sleeper stretches to restore total arc.
Return-to-Play Criteria Returning to matches before strength recovery 42% high re-injury recurrence rate 90% Symmetry Law: Pass objective isometric and 240fps video benchmarks before competing.